Epidemiology of Pediatric Bacterial Meningitis in Japan: A Multicenter Survey, 2022–2024

Clicks: 14
ID: 330874
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #63 of 145 articles by views in journal of the pediatric infectious diseases society

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 145 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Abstract Background Bacterial meningitis remains a life-threatening condition among infants and young children worldwide, even in the era of advanced antimicrobial therapy and widespread vaccination. As part of ongoing multicenter surveillance in Japan, we investigated the recent epidemiology of pediatric bacterial meningitis during 2022–2024. Methods We conducted a multicenter retrospective study of children aged 0–14 years diagnosed with bacterial meningitis in Japan between January 2022 and December 2024. Data were collected using a standardized survey to characterize current epidemiology, age-specific pathogen and pneumococcal serotype patterns, and predictors of poor outcome. Multivariable logistic regression analysis was performed to identify independent predictors of poor outcome. Results Of 206 bacterial meningitis cases, 124 (60.2%) were community-acquired and the remaining 82 (39.8%) were healthcare-associated. Eight patients (3.9%) died–four in each group. Streptococcus agalactiae, Escherichia coli, and Streptococcus pneumoniae collectively accounted for 81.5% of community-acquired cases. S. agalactiae predominantly affected neonates and infants up to age 4 months, whereas E. coli was detected from the neonatal period through age 6 months. Among E. coli isolates, 15% (3/20) were extended-spectrum β-lactamase producers. S. pneumoniae was more common after age 4 months; 45.5% (10/22) of isolates were penicillin resistant, and all serotyped isolates were non-PCV13 serotypes. Multivariable analysis identified cerebrospinal fluid glucose level <20 mg/dL as an independent predictor of poor outcome. Conclusions This multicenter survey highlights the continued predominance of S. agalactiae, E. coli, and S. pneumoniae as the major causative pathogens of pediatric bacterial meningitis in Japan. Ongoing challenges–including antimicrobial resistance, serotype replacement, and healthcare-associated meningitis–underscore the need for continued surveillance.
Reference Key
openalex_W7219058125 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Kentaro Tomita, Munehiro Furuichi, Mizuki Yaginuma, Satoshi Iwata, Satoshi Narumi, Masayoshi Shinjoh
Journal journal of the pediatric infectious diseases society
Year 2026
DOI
10.1093/jpids/piag106
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.